Beiersdorf, DE0005200000

Beiersdorf stock faces lower targets as Nivea reset weighs

Published on 10/04/2026 at 16:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Beiersdorf stock reflects a EUR 74 fair value after DZ Bank cut its view on October 1, 2026. First-half revenue fell 4.5 percent to EUR 4.95 billion.

Moderner Unternehmens-Campus mit Glasfassade, symmetrische Architektur, bewölkter Himmel — Architekturaufnahme eines modernen Unternehmens-Campus: symmetrische Fassade aus Glas und hellem Beton, nordeuropäisches Tageslicht, grüne Bepflanzung, kein Schriftzug, Illustration mit AI erstellt.

Beiersdorf stock (ISIN DE0005200000) closed at EUR 75.400 on Xetra on October 2, 2026, down 0.48 percent from the previous close. The latest analyst action came from finanzen.net on October 1, 2026, which reported that DZ Bank reduced its fair value from EUR 77 to EUR 74 and retained a Hold rating.

Nivea remains the central issue

DZ Bank said the recovery of Nivea could take time, while higher marketing spending, more local products and lower-priced launches are intended to restore momentum. The same assessment placed strong dermatology brands on the other side of the portfolio, creating a sharper split between Beiersdorf's business areas.

finanznachrichten.de reported on September 28, 2026, that Jefferies also cut its target from EUR 76 to EUR 74 and kept a Hold rating. Its view cited inventory reductions in Western Europe, retailer tensions and frozen Russian assets, while it described dermatology as performing well.

First-half revenue declined 4.5 percent

The first half of 2026 delivered revenue of EUR 4.95 billion, down 4.5 percent from the first half of 2025, while net income was EUR 551.0 million and broadly flat year over year. Adjusted or reported labels matter here: the figures are reported first-half results, and diluted EPS rose to EUR 2.52 from EUR 2.47, according to Simply Wall St.

That mix gives investors two measurable signals. Earnings per share improved by EUR 0.05, but the revenue decline shows why analysts are concentrating on the Nivea reset and the pace of recovery before the next report.

Consensus target sits above the stock

The analyst consensus published by Investing.com covers 20 analysts and is Neutral. Its average 12-month target is EUR 81.579, with a high of EUR 95 and a low of EUR 67; the average target lies 8.19 percent above the October 2 price of EUR 75.400.

Stock remains below its yearly high

Beiersdorf's market capitalization was EUR 16.44 billion as of October 2, 2026, while the Xetra 52-week range stood at EUR 67.080 to EUR 110.150. The closing price was 31.5 percent below the upper end of that range, keeping the Nivea turnaround and the October results as the next major valuation tests.